The Insides Company and OptiMed Technologies Announce Australia Distribution Agreement
OptiMed Technologies Pty Ltd has been appointed as the exclusive distributor for The Insides Company's therapeutic chyme reinfusion solutions for Australia.
Garth Sutherland, CEO of The Insides Company said "The Insides Company is very excited for our new partnership with OptiMed Technologies, an outstanding and reputable medical device distributor who share the same vision of providing excellent innovation to improve patient outcomes."
Michael Hleis, Managing Director of Optimed Technologies said "OptiMed Technologies is proud to announce our new partnership with The Insides Company as we see great synergy in both organisations' professionalism, ethics and commitment to optimising patient care and clinical outcome. The clinical, technical and market expertise this joint partnership offers further strengthens our capacity to provide excellence in the quality of Healthcare to both our clinicians and patients."
The Insides Company is the leading provider of therapeutic chyme reinfusion solutions for intestinal failure. The Insides Company's flagship product, The Insides System, reestablishes intestinal continuity by enabling chyme to be reinfused back into the distal limb of a patient's fistula or stoma.